About 1 result found for searched term "Letolizumab" (0.129 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24688 | Letolizumab | TNF Receptor |
| BMS-986004 | ||
| Letolizumab (BMS-986004) is a dimer antibody construction targeting CD40L, which is produced to express mutant IgG1 lacking effector function, including Fc binding and complement fixation. Letolizumab reduces rejection, thromboembolism and prolongs the survival time. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
